Menopause Active Not Recruiting Phase 2 Trials for Durvalumab (DB11714)

Also known as: Menopausal

IndicationStatusPhase
DBCOND0025857 (Menopause)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02997995Durvalumab and Endocrine Therapy in ER+/Her2- Breast Cancer After CD8+ Infiltration Effective Immune-Attractant ExposureTreatment